Middle East gains breast cancer blood test
This article was originally published in Clinica
US company Power3 Medical Products has launched its breast cancer diagnostic blood test BC-SeraPro in 12 Middle Eastern countries. The Texas-based company (The Woodlands) expects the test to be performed in conjunction with mammography, and believes that it will help reduce the number of patients subjected to erroneous results from mammograms - which is allegedly 50% of women screened in the US.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.